These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37634309)

  • 41. Prediction of very early major bleeding risk in acute pulmonary embolism: an independent external validation of the Pulmonary Embolism-Syncope, Anemia, and Renal Dysfunction (PE-SARD) bleeding score.
    Villiger R; Méan M; Stalder O; Limacher A; Rodondi N; Righini M; Aujesky D
    J Thromb Haemost; 2023 Oct; 21(10):2884-2893. PubMed ID: 37149148
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of Bleeding Risk Scores in Elderly Patients Receiving Extended Anticoagulation with Vitamin K Antagonists for Venous Thromboembolism.
    Frei AN; Stalder O; Limacher A; Méan M; Baumgartner C; Rodondi N; Aujesky D
    Thromb Haemost; 2021 Nov; 121(11):1512-1522. PubMed ID: 33930905
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative Performance of Clinical Risk Assessment Models for Hospital-Acquired Venous Thromboembolism in Medical Patients.
    Blondon M; Spirk D; Kucher N; Aujesky D; Hayoz D; Beer JH; Husmann M; Frauchiger B; Korte W; Wuillemin WA; Bounameaux H; Righini M; Nendaz M
    Thromb Haemost; 2018 Jan; 118(1):82-89. PubMed ID: 29304528
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism. A multicentre retrospective cohort study.
    Riva N; Bellesini M; Di Minno MN; Mumoli N; Pomero F; Franchini M; Fantoni C; Lupoli R; Brondi B; Borretta V; Bonfanti C; Ageno W; Dentali F
    Thromb Haemost; 2014 Sep; 112(3):511-21. PubMed ID: 24899092
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials.
    Spyropoulos AC; Raskob GE; Cohen AT; Ageno W; Weitz JI; Spiro TE; Lu W; Lipardi C; Albers GW; Elliott CG; Halperin JL; Hiatt WR; Maynard G; Steg PG; Sugarmann C; Barnathan ES
    Circulation; 2022 May; 145(19):1471-1479. PubMed ID: 35389229
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pharmacological Thromboprophylaxis in Acutely Ill Hospitalized Medical Patients].
    Kantor B; Poénou G; Plaisance L; Toledano E; Mekhloufi Y; Helfer H; Djennaoui S; Mahé I
    Rev Med Interne; 2022 Jan; 43(1):9-17. PubMed ID: 33895004
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Superior Predictive Value of D-Dimer to the Padua Prediction Score for Venous Thromboembolism in Inpatients with AECOPD: A Multicenter Cohort Study.
    Zhou C; Guang Y; Luo Y; Ge H; Wei H; Liu H; Zhang J; Pan P; Zhang J; Peng L; Aili A; Liu Y; Pu J; Zhong X; Wang Y; Yi Q; Zhou H;
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2711-2722. PubMed ID: 36304969
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism.
    Robertson L; Yeoh SE; Ramli A
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011088. PubMed ID: 29244199
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism.
    Palareti G; Antonucci E; Mastroiacovo D; Ageno W; Pengo V; Poli D; Testa S; Tosetto A; Prandoni P
    J Thromb Haemost; 2018 Oct; 16(10):1994-2002. PubMed ID: 30059189
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Renal Impairment, Recurrent Venous Thromboembolism and Bleeding in Cancer Patients with Acute Venous Thromboembolism-Analysis of the CATCH Study.
    Bauersachs R; Lee AYY; Kamphuisen PW; Meyer G; Janas MS; Jarner MF; Khorana AA;
    Thromb Haemost; 2018 May; 118(5):914-921. PubMed ID: 29618162
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.
    Kahn SR; Morrison DR; Cohen JM; Emed J; Tagalakis V; Roussin A; Geerts W
    Cochrane Database Syst Rev; 2013 Jul; (7):CD008201. PubMed ID: 23861035
    [TBL] [Abstract][Full Text] [Related]  

  • 52. External validation of the risk assessment model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for medical patients in a tertiary health system.
    Rosenberg D; Eichorn A; Alarcon M; McCullagh L; McGinn T; Spyropoulos AC
    J Am Heart Assoc; 2014 Nov; 3(6):e001152. PubMed ID: 25404191
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
    Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD004318. PubMed ID: 30916777
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolism.
    Leiss W; Méan M; Limacher A; Righini M; Jaeger K; Beer HJ; Osterwalder J; Frauchiger B; Matter CM; Kucher N; Angelillo-Scherrer A; Cornuz J; Banyai M; Lämmle B; Husmann M; Egloff M; Aschwanden M; Rodondi N; Aujesky D
    J Gen Intern Med; 2015 Jan; 30(1):17-24. PubMed ID: 25143224
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and safety of direct oral anticoagulants for the treatment of cancer-associated venous thromboembolism: A systematic review and Bayesian network meta-analysis.
    Ning H; Yang N; Ding Y; Chen H; Wang L; Han Y; Cheng G; Zou M
    Med Clin (Barc); 2023 Mar; 160(6):245-252. PubMed ID: 36031454
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators.
    Decousus H; Tapson VF; Bergmann JF; Chong BH; Froehlich JB; Kakkar AK; Merli GJ; Monreal M; Nakamura M; Pavanello R; Pini M; Piovella F; Spencer FA; Spyropoulos AC; Turpie AG; Zotz RB; Fitzgerald G; Anderson FA;
    Chest; 2011 Jan; 139(1):69-79. PubMed ID: 20453069
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
    Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD004318. PubMed ID: 30481366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thromboprophylaxis in Hospitalized Non-Critically Ill Patients With Mild-to-Moderate COVID-19 Infection: A Systematic Review and Meta-Analysis.
    Hafiz A; Alkofide H; Al Sulaiman K; Joharji H; Aljohani S; Sarkhi KA; Alharbi R; Korayem GB; AlFaifi M; Alsohimi S; Aljuhani O
    Clin Appl Thromb Hemost; 2023; 29():10760296231191123. PubMed ID: 37547931
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry.
    Ruíz-Giménez N; Suárez C; González R; Nieto JA; Todolí JA; Samperiz AL; Monreal M;
    Thromb Haemost; 2008 Jul; 100(1):26-31. PubMed ID: 18612534
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Venous Thromboembolism Prophylaxis in Acute Medically Ill Patients: A Retrospective Cohort Study.
    Gafter-Gvili A; Drozdinsky G; Zusman O; Kushnir S; Leibovici L
    Am J Med; 2020 Dec; 133(12):1444-1452.e3. PubMed ID: 32445719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.